mycolactone has been researched along with Edema* in 2 studies
1 review(s) available for mycolactone and Edema
Article | Year |
---|---|
[Role of mycolactone in the nerve damage of Buruli ulcer (Mycobacterium ulcerans infection)].
Buruli ulcer is a skin disease caused by Mycobacterium ulcerans (M. ulcerans). In this review, we introduce our recent studies and other important works. Lesions of Buruli ulcer are usually painless, despite the extensive tissue necrosis. We have reported that mice inoculated with M ulcerans show nerve degeneration and absence of pain, but the mechanism evoking the nerve damage have not been clarified. In order to define whether mycolactone, a toxic lipid produced by M. ulcerans, can induce nerve damages, we have injected mycolactone A/B to BALB/c mouse footpads. Mycolactone induced footpad swelling, and sensory test showed hyperesthesia on day 7 and 14, recovery on day 21, and hypoesthesia on days 28 and 42. Histologically, nerve bundles showed hemorrhage, neutrophilic infiltration, and loss of Schwann cell nuclei on days 7 and 14. Semithin section studies revealed vacuolar change of Schwann cells started on day 14, which subsided by day 42, but myelinated fiber density remained low. This study suggests that mycolactone directly damages nerves and is responsible for the absence of pain characteristic of Buruli ulcer. In the human lesions, presence of neuritis is reported (Rondini S, 2006), and murine studies showed "autoamputation" (Addo P, 2005). In order to prevent the serious deformities evoked by Buruli ulcer, further studies are necessary. Topics: Animals; Bacterial Toxins; Buruli Ulcer; Edema; Female; Humans; Macrolides; Mice; Mice, Inbred BALB C; Mycobacterium ulcerans; Nerve Degeneration; Peripheral Nerves; Schwann Cells; Sensation Disorders | 2011 |
1 other study(ies) available for mycolactone and Edema
Article | Year |
---|---|
Mycobacterial toxin induces analgesia in buruli ulcer by targeting the angiotensin pathways.
Mycobacterium ulcerans, the etiological agent of Buruli ulcer, causes extensive skin lesions, which despite their severity are not accompanied by pain. It was previously thought that this remarkable analgesia is ensured by direct nerve cell destruction. We demonstrate here that M. ulcerans-induced hypoesthesia is instead achieved through a specific neurological pathway triggered by the secreted mycobacterial polyketide mycolactone. We decipher this pathway at the molecular level, showing that mycolactone elicits signaling through type 2 angiotensin II receptors (AT2Rs), leading to potassium-dependent hyperpolarization of neurons. We further validate the physiological relevance of this mechanism with in vivo studies of pain sensitivity in mice infected with M. ulcerans, following the disruption of the identified pathway. Our findings shed new light on molecular mechanisms evolved by natural systems for the induction of very effective analgesia, opening up the prospect of new families of analgesics derived from such systems. Topics: Analgesics; Angiotensins; Animals; Buruli Ulcer; Disease Models, Animal; Edema; Humans; Hypesthesia; Macrolides; Mice; Mycobacterium ulcerans; Neurons; Potassium Channels; Prostaglandin-Endoperoxide Synthases; Receptor, Angiotensin, Type 2; Signal Transduction | 2014 |